SALMET-VEC
Live / Registered — Registered (as of 20 Jul 2021)
What this means for you
Registered since 20 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88697201
- Registration number
- 6429132
- Mark type
- Design + words
- Filed
- 18 Nov 2019
- Published for opposition
- 12 May 2020
- Registered
- 20 Jul 2021
- Attorney of record
- Kevin O'Keefe
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant part, gene therapy substances
Owner
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
- Guangzhou Sinogen Pharmaceutical Co., Ltd., Guangzhou, CN
Prosecution history
- 07 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Mar 2021 — NON-FINAL ACTION E-MAILED
- 02 Mar 2021 — SU - NON-FINAL ACTION - WRITTEN
- 26 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2021 — USE AMENDMENT FILED
- 26 Jan 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL